EAPC Premium Access

Multiple vascular endothelial growth factor (-receptor) polymorphisms modify the treatment benefit of ACE-inhibitors on cardiovascular outcome

Topic: Pharmacology and Pharmacotherapy, Other

Congress Presentation

About the speaker

Ms Nermina Buljubasic

Erasmus University Medical Centre, Rotterdam (Netherlands (The))
0 follower

7 more presentations in this session

Cost-effectiveness of guideline adherence in coronary patients: results from the EUROASPIRE IV survey - a registry from the european society of cardiology

Speaker: Doctor D. De Smedt (Ghent, BE)

Thumbnail

LDL extracellular vesicle coagulation protein levels change after initiation of statin therapy in patients with subclinical atherosclerosis. Findings from the METEOR trial

Speaker: Ms L. Willemsen (Utrecht, NL)

Thumbnail

Relationship between the shift of socioeconomic status and cardiovascular mortality

Speaker: Doctor J. Sung (Seoul, KR)

Thumbnail

Excess mortality of non-participants indicates that low participation rates in health examination surveys bias population level risk factor estimates

Speaker: Doctor H. Tolonen (Helsinki, FI)

Thumbnail

Endothelial microparticles-mediated transfer of microRNA-19b promotes atherosclerosis via targeting RNF-11

Thumbnail

Access the full session

Rapid Fire Session I

Speakers: Ms N. Buljubasic, Doctor D. De Smedt, Ms L. Willemsen, Doctor J. Sung, Doctor H. Tolonen
Thumbnail

About the event

Image

EuroPrevent 2018

19 April - 21 April 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb